Catheter mislabelling leads to Boston Scientific recall in Brazil:
This article was originally published in Clinica
Executive Summary
Boston Scientific is recalling two lots of its Guider Softip XF guide catheters in Brazil, as a result of a "quality deviation" involving a product/labelling mismatch, regulatory agency Anvisa reports. According to a July 19 notice, the affected lots of 90cm and 100cm catheters were distributed with labelling describing them as being 100cm and 90cm, respectively. Sao Paulo-based Boston Scientific do Brasil reportedly received two surveillance alerts and has confirmed to Anvisa that only two lots were affected. The risk the transposed descriptions pose is that the surgical procedure might be delayed or protracted, according to the agency.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.